2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Sunday, April 30, 2017

5:18pm-5:30pm: Treating Hepatitis C+ Patients Before or After Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd,¹ K. Tennankore,¹ K. Doucette.²

Concurrent Session: New Insights - HCV / HIV • E271b

5:18pm-5:30pm: Waitlist Desensitization and the Rate of Deceased Donor Kidney Transplantation After Implementation of the Kidney Allocation System.

E. Huang, S. Jordan, R. Najjar, J. Choi, A. Peng, A. Vo.

Concurrent Session: Kidney Allocation: Changes and Consequences • E450a

5:30pm-5:42pm: Access to Simultaneous Pancreas and Kidney Transplant (SPK) Should Not Be Restricted to BMI > 28.

M. Laftavi, A. Gruessner, V. Whittaker, Z. Acun, O. Pankowycz, R. Gruessner.

Concurrent Session: Pancreas Transplantation • E267

5:30pm-5:42pm: Ambulatory Antibiotic Utilization and Outcomes in an Adult Kidney Transplant Population: A Pharmacovigilance Analysis.

L. Avery, C. Fominaya, R. Crawford, D. Taber.

Concurrent Session: Kidney Clinical Complications 1 • E354a

5:30pm-5:42pm: Changes in Peripheral Blood Gene Expression Profile After Calcineurin Inhibitor (CNI) Withdrawal in Kidney Transplant Recipients.

P. Cravedi,¹ W. Zhang,¹ D. Salomon,² M. Fribourg,¹ G. Remuzzi,³ E. Gotti,³ F. Casiraghi,³ Z. Yi,¹ P. Heeger,¹ CTOT09, ATHENA Consortia.

Concurrent Session: Novel Immunosuppression - DSA Monitoring • E450b

5:30pm-5:42pm: Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

J. Putra,¹ T. Schiano,² M. Fiel.¹

Concurrent Session: Liver: Viral Hepatitis • E271a

5:30pm-5:42pm: Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant.

A. Vo, J. Choi, I. Kim, E. Huang, S. Louie, A. Kang, S. Williamson, K. Myers, A. Peng, R. Najjar, S. Jordan.

Concurrent Session: Clinical Science: Kidney Immunosuppression: Desensitization • E354b

5:30pm-5:42pm: Impact of mTOR-Inhibition on Tolerance-Induction Following Heart Transplantation.

M.-T. Dieterlen, K. Klaeske, J. Fischer, J. Hahn, K. Jawad, J. Garbade, F. Mohr, S. Lehmann.

Concurrent Session: Tolerance: Clinical Studies • E353C

5:30pm-5:42pm: Kidney Quality Dramatically Influences Patient and Death Censored Graft Survival in SLK Recipients.

T. Zens, J. Danobeitia, P. Stahler, G. Leverson, R. Redfield, A. D'Alessandro, L. Fernandez.

Concurrent Session: Liver Allocation, Utilization, and Machine Perfusion • E451a

5:30pm-5:42pm: Knowledge and Attitudes Associated with Willingness to Accept HIV+ Organs Among Persons Living with HIV.

S. Anjum, S. Halpern, K. Kumar, A. Nyugen, S. Rasmussen, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.

Concurrent Session: New Insights - HCV / HIV • E271b